Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app help Moms-to-Be control gestational diabetes?

NCT ID NCT07318740

Symptom relief Sponsor: Saglik Bilimleri Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a mobile app called SugarMoms, which provides education and counseling, can help pregnant women with gestational diabetes improve their self-management skills and confidence. About 94 women will be split into two groups: one using the app plus standard care, and the other receiving only standard hospital education. Researchers will measure changes in attitudes, behaviors, and self-efficacy over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mobile application-based education and counseling program (SugarMoms app)
What this could lead to
If successful, this approach could provide an effective, convenient way for pregnant women with gestational diabetes to manage their condition and improve their self-care behaviors.
What could go wrong
This is a small, early-stage study with only 94 participants, so results may not apply to all women. The app's effectiveness depends on user engagement and may not outperform standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 94 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Pregnant women aged ≥18 years. Minimum education level: primary school graduate. Singleton pregnancy. No prior diagnosis of gestational diabetes mellitus (GDM). Newly diagnosed with GDM based on oral glucose tolerance test (OGTT) results. Currently receiving insulin treatment as part of the clinical management plan. Absence of comorbid conditions such as hypertension, preeclampsia, or other chronic diseases. Ability to read and understand Turkish. Ownership of a smartphone (iOS/Android) with internet access. Willingness to participate and provide written informed consent. Exclusion Criteria: Development of pregnancy-related complications during the follow-up period. Incomplete or missing data in the study forms. Non-compliance with study protocol. Withdrawal from the study at the participant's request.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gestational diabetes mellitus (GDM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gestational diabetes mellitus (GDM)

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, 06170, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.